New blood test could tell doctors which lung cancer treatment will work
NCT ID NCT07392073
Summary
This study aims to find out if a new blood test can predict which patients with advanced lung cancer will respond best to a standard combination of chemotherapy and immunotherapy. Researchers will measure specific immune cells in the blood of 80 patients before and during treatment to see if changes in these cells are linked to better outcomes. The goal is to develop a better tool to help doctors choose the most effective treatment for each patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.